Vienna and Lower Austria locked in bitter cancer treatment funding row
Vienna and Lower Austria locked in bitter cancer treatment funding row
Vienna and Lower Austria locked in bitter cancer treatment funding row
Dispute Over Cross-Border Patients: Vienna and Lower Austria Remain at Odds
The standoff between Vienna and Lower Austria over out-of-region patients shows no signs of easing, as each side views the issue through a different lens—depending on which side of the state border they stand. On Tuesday, the Lower Austrian People's Party (ÖVP) used its platform to critique Vienna's healthcare policies, taking the MedAustron cancer research and treatment center as a case study to outline its own approach to cross-border patient care.
Officials emphasized that the facility—fully funded by financial guarantees from Lower Austria—knows no state borders. They omitted mention of the federal government's initial seed funding but highlighted that 25 percent of MedAustron's patients come from Vienna and, of course, receive treatment. With 3,600 patients treated over the past decade, that amounts to roughly 90 Viennese patients per year.
12,000 vs. 90
Vienna has countered with its own figures, detailing the number of cancer patients from Lower Austria treated in the capital last year alone. The data reveals 12,000 individuals—22 percent of all outpatient oncology cases in Vienna. This includes 2,300 patients who received 25,000 oncological treatments and chemotherapy sessions, 5,500 who underwent 68,000 nuclear medicine and radiotherapy procedures, and 2,800 who had surgery for cancer in Vienna.
"Structural Imbalance" in Funding
Vienna's healthcare network, WIGEV, also employs tumor boards for diagnostic clarity in these cases. The city points to a "structural imbalance" in financing: while social insurance funds—used to bill treatments at MedAustron—are pooled nationwide, funds for inpatient care are allocated based on residential population.
As a result, Vienna must cover the costs of treating Lower Austrians in its hospitals—a provision enshrined in the fiscal equalization agreement. The city is now calling for a return to objective debate and a "fact-based resolution of the funding logic" to address the dispute.